<p>SUNSHINE PHARMA (06887.HK) announced its interim results for the six months ended June, with revenue of RMB 1.938 billion, a year-on-year decrease of 25%. It recorded a loss of RMB 46.37 million, compared to a net profit of RMB 142 million in the same period last year, turning from profit to loss; loss per share was 11 cents. No dividend was declared</p>

06887

<p>SUNSHINE PHARMA announced its interim results for the six months ended June, with revenue of RMB 1.938 billion, a year-on-year decrease of 25%. It recorded a loss of RMB 46.37 million, compared to a net profit of RMB 142 million in the same period last year, turning from profit to loss; the loss per share is 11 cents. No dividend is declared</p>

"Performance" SUNSHINE PHARMA reported a mid-term loss of 46.37 million RMB, turning from profit to loss